BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23296257)

  • 1. The risk of childhood leukaemia following exposure to ionising radiation--a review.
    Wakeford R
    J Radiol Prot; 2013 Mar; 33(1):1-25. PubMed ID: 23296257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukaemia following childhood radiation exposure in the Japanese atomic bomb survivors and in medically exposed groups.
    Little MP
    Radiat Prot Dosimetry; 2008; 132(2):156-65. PubMed ID: 18936088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation and cancer risk in atomic-bomb survivors.
    Kodama K; Ozasa K; Okubo T
    J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation.
    Little MP; Wakeford R; Kendall GM
    J Radiol Prot; 2009 Dec; 29(4):467-82. PubMed ID: 19923647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation epidemiology: a perspective on Fukushima.
    Boice JD
    J Radiol Prot; 2012 Mar; 32(1):N33-40. PubMed ID: 22395193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood leukaemia following medical diagnostic exposure to ionizing radiation in utero or after birth.
    Wakeford R
    Radiat Prot Dosimetry; 2008; 132(2):166-74. PubMed ID: 18922822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
    Little MP; Hall P; Charles MW
    Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000.
    Richardson D; Sugiyama H; Nishi N; Sakata R; Shimizu Y; Grant EJ; Soda M; Hsu WL; Suyama A; Kodama K; Kasagi F
    Radiat Res; 2009 Sep; 172(3):368-82. PubMed ID: 19708786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
    Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
    Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: support for the ICRP lung model.
    Little MP
    Int J Radiat Biol; 2002 Mar; 78(3):145-63. PubMed ID: 11869470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological studies of Fukushima residents exposed to ionising radiation from the Fukushima Daiichi Nuclear Power Plant prefecture--a preliminary review of current plans.
    Akiba S
    J Radiol Prot; 2012 Mar; 32(1):1-10. PubMed ID: 22327057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.
    Preston DL; Cullings H; Suyama A; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K; Kasagi F; Shore RE
    J Natl Cancer Inst; 2008 Mar; 100(6):428-36. PubMed ID: 18334707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in childhood leukaemia in the Nordic countries in relation to fallout from atmospheric nuclear weapons testing.
    Darby SC; Olsen JH; Doll R; Thakrar B; Brown PD; Storm HH; Barlow L; Langmark F; Teppo L; Tulinius H
    BMJ; 1992 Apr; 304(6833):1005-9. PubMed ID: 1586779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The third analysis of cancer mortality among Japanese nuclear workers, 1991-2002: estimation of excess relative risk per radiation dose.
    Akiba S; Mizuno S
    J Radiol Prot; 2012 Mar; 32(1):73-83. PubMed ID: 22392887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL; Kusumi S; Tomonaga M; Izumi S; Ron E; Kuramoto A; Kamada N; Dohy H; Matsuo T; Matsui T [corrected to Matsuo T]
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the risks of cancer incidence and mortality following radiation therapy for benign and malignant disease with the cancer risks observed in the Japanese A-bomb survivors.
    Little MP
    Int J Radiat Biol; 2001 Apr; 77(4):431-64. PubMed ID: 11304437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fallout from Chernobyl and incidence of childhood leukaemia in Finland, 1976-92.
    Auvinen A; Hakama M; Arvela H; Hakulinen T; Rahola T; Suomela M; Söderman B; Rytömaa T
    BMJ; 1994 Jul; 309(6948):151-4. PubMed ID: 8044092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.